| 1. |
Fernandez-Puentes, C., and Carrasco, L. (1980) Viral infection permeabilizes mammalian cells to protein toxins Cell
20, 769–775
|
| |
| 2. |
Fitzgerald, D., Padmanabhan, R., Pastan, I., and Wilhngham, M. (1983) Adenovirus-induced release of epidermal growth factor
and Pseudomonas toxin into the cytosol of KB cells during receptor-mediated endocytosis. Cell
32, 607–617.
|
| |
| 3. |
Carrasco, L. (1994) Entry of animal viruses and macromolecules into cells FEBs Lett. 350, 151–154
|
| |
| 4. |
Carrasco, L. (1995) Modification of membrane permeability by animal viruses. Adv Virus Res
45, 61–112.
|
| |
| 5. |
Cunel, D. T., Agarwal, S., Wagner, E., and Cotten, M. (1991) Adenovirus enhancement oftransferrin-polylysine mediated gene
delivery Proc Natl Acad. Sci USA 88, 8850–8854
|
| |
| 6. |
Wagner, E., Zatloukal, K., Cotten, M., Kiriappos, H., Mechtler, K., Cunel, D.,and Birnstiel, M. L. (1992) Coupling of adenovirus
to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected cells.
Proc Natl Acad. Sci USA 89, 6099–6103
|
| |
| 7. |
Cotten, M., Wagner, E., Zatloukal, K., Phillips, S., Cunel, D., and Birnstiel, M. L. (1992) High-efficiency receptor-mediated
delivery of small and large (48 kb) gene constructs using the endosome-disruption activity of defective or chemically-inactivated
adenovirus particles. Proc. Natl Acad Sci USA 89, 6094–6098.
|
| |
| 8. |
Defer C, Behn, M., Caillet-Boudm, M., and Boulanger, P. (1990) Human adenovirus-host cell interactions: comparative study
with members of subgroups B and C J Virol
64, 3661–3673.
|
| |
| 9. |
Greber, U. F., WiUetts, M., Webster, P., and Helenius, A. (1993) Stepwise dis-mantling of adenovirus 2 during entry into cells.
Cell
75, 1–20.
|
| |
| 10. |
Greber, U. F., Webster, P., Weber, J., and Helenius, A. (1996) The role of the adenovirus protease in virus entry into cells
EMBOJ
15, 1766–1777.
|
| |
| 11. |
Cnstiano, R. J., Smith, L. C, Kay, M. A., Bnnkley, B. R, and Woo, S. L. C. (1993) Hepatic gene therapy: efficient gene delivery
and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex [itProc Natl Acad.Sci. USA, 11, 548–552
|
| |
| 12. |
Fisher, K. J. and Wilson, J. M. (1994) Biochemical and functional analysis of an adenovirus-based hgand complex for gene transfer.
Biochem J
299, 49–58.
|
| |
| 13. |
Wu, G., Zhan, P., Sze, L., Rosenberg, A., and Wu, C. (1994) Incorporation of adenovirus into a hgand-based DNA carrier system
results in retention of original receptor specificity and enhances targeted gene expression. J Biol Chem
269, 11,542–11,5
|
| |
| 14. |
Fisher, K. J., Kelley, W. M., Burda, J. F., and Wilson, J. M. (1996) A novel adenovirus-adeno-associated virus hybrid vector
that displays efficient rlscue and delivery of the AAV genome.Human Gene Ther
7, 2079–2087.
|
| |
| 15. |
Zatloukal, K., Wagner, E., Cotten, M., Phillips, S., Plank, C., Steinlein, P., Cunel, D., and Birnstiel, M. L. (1992) Transfernnfection.
a highly efficient way to express gene constructs in eukaryotic cells. Ann New York Acad Sci
660, 136–153.
|
| |
| 16. |
Cotten, M., Baker, A., Birnstiel, M. L., Zatloukal, K., and Wagner, E. (1996) Adenovirus polylysine DNA conjugates Curr Protocols Human Genet 12.3.1–12.3.33.
|
| |
| 17. |
Curiel, D., Wagner, E., Cotten, M., Birnstiel, M. L., Li, C., Loechel, S., Agarwal, S., and Hu, P. (1992) High efficiency
gene transfer mediated by adenovirus coupled to DNA polylysme complexes via an antibody bridge. Human Gene Ther
3, 147–154.
|
| |
| 18. |
Wagner, E., Cunel, D., and Cotten, M. (1994) Delivery of drugs, proteins and genes into cells using transferrin as a ligand
for receptor-mediated endocytosis Adv Drug Delivery Rev
14, 113–135.
|
| |
| 19. |
Findeis, M. A., Wu, C. H., and Wu, G. Y. (1994) Ligand-based carrier systems for delivery of DNA to hepatocytes. Methods Enzymol
247, 341–351.
|
| |
| 20. |
Perales, J. C., Ferkol, T., Molas, M., and Hanson, R. W. (1994) An evaluation of receptor-mediated gene transfer using synthetic
DNA-hgand complexes Eur J Bwchem. 226, 255–266.
|
| |
| 21. |
Curiel, D. T. (1993) Adenovirus facilitation of molecular conjugate-mediated gene transfer Prog. Med Virol
40, 1–18.
|
| |
| 22. |
Douglas, J. T., and Cunel, D. T. (1995) Targeted gene therapy Tumor Targeting
1, 67–84.
|
| |
| 23. |
Cotten, M. (1995) The entry mechanism of adenovirus and some solutions to the oxicity problems associated with adenovirus-augmented,
receptor-mediated gene delivery, in The Molecular Repertoire of Adenoviruses III (Doerfler, W and Bohm, P, eds) Current Topics in Microbiology and Immunology, vol 199/111,pp 283–295 Springer, Berlin-Heidelberg.
|
| |
| 24. |
Cotten, M., and Wagner, E. (1993) Non-viral approaches to gene therapy. Citurr. Opin. Biotech 4, 705–710.
|
| |
| 25. |
Ledley, F. (1994) Non-viral gene therapy. Curr Opin Biotech
5, 626–636.
|
| |
| 26. |
Boussif, O., Lezoualc’h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., and Behr, J. P. (1995) A versatile vector
for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl Acad Sci USA. 92, 7297–7301.
|
| |
| 27. |
Abdallah, B., Hassan, A., Benoist, C., Goula, D., Behr, J. P., and Demeneix, B. A. (1996) A powerful nonviral vector for in
vivo gene transfer into the adult mam-malian brain. polyethylenimine Human Gene Ther
7, 1947–1954.
|
| |
| 28. |
Baker, A., and Cotten, M. (1997) Useful delivery of bacterial artificial chromosomes into mammalian cells using psoralen-inactivated
adenovirus carrier. Nucleic Acids Res
25, 1950–1956.
|
| |
| 29. |
Baker, A., Saltik, M., Lehrmann, H., Killisch, I., Mautner, V., Lamm, G., Chnstofori, G., and Cotten, M. (1997) Polyethylenimine
is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery Gene Ther
4, 773–782.
|
| |
| 30. |
Bordier, C. (1981) Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol Chem
256, 1604–1607.
|
| |
| 31. |
Bridge, E., and Ketner, G. (1989) Redundant control of adenovirus late gene expression by early region 4 J. Virol
63, 631–638.
|
| |
| 32. |
Weinberg, D. H., and Ketner, G. (1983) A cell line that supports the growth of adefective early region 4 deletion mutant of
human adenovirus type 2. Proc Natl. Acad Sci. USA 80, 5383–5386.
|
| |
| 33. |
Cotten, M., Saltik, M., Kursa, M., Wagner, E., Maass, G., and Birnstiel, M. (1994) Psoralen treatment of adenovirus particles
eliminates virus replication and transcription while maintaining the endosomolytic activity of the virus capsid Virology
205, 254–261.
|
| |
| 34. |
Chardonnet, Y., and Dales, S. (1970) Early events in the interaction of adenoviruses with HeLa cells: penetration of type
5 and intracellular release of the DNA genome. Virology
40, 462–477.
|
| |
| 35. |
Mittereder, N., March, K. L., and Trapnell, B. C. (1996) Evaluation of the concentration and bioactivity of adenovirus vectors
for gene therapy J Virol
70, 7498–7509.
|
| |
| 36. |
Lemay, P., Boudin, M., Milleville, M., and Boulanger, P. (1980) Human adenovirus type 2 protein Ilia. I Purification and characterization
Virology
101, 131–143.
|
| |
| 37. |
Cotten, M., Baker, A., Saltik, M., Wagner, E., and Buschle, M. (1994) Lipopolysacchande is a frequent contaminant of plasmid
DNA preparations and can be toxic to primary cells in the presence of adenovirus. Gene Ther
1, 239–246.
|
| |
| 38. |
Cotten, M., and Saltik, M. (1997) Intracellular delivery of LPS during DNA transfection activates a lipid A-dependent cell
death response that can be prevented by polymyxin B. Human Gene Ther
8, 555–562.
|
| |
| 39. |
Manthorpe, M, Cornefert-Jensen, F., Hartikka, J., Feigner, J., Rundell, A., Margahth, M., and Dwarki, V. (1993) Gene therapy
by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice Human Gene Ther
4, 419–431.
|
| |
| 40. |
Aida, Y., and Pabst, M. J. (1990) Removal of endotoxin from protein solutions by phase separation using Triton X-114. J Immunol. Methods
132, 191–195.
|
| |
| 41. |
Cotten, M., Wagner, E., and Birnstiel, M. L. (1993) Receptor-mediated transport of DNA into eukaryotic cells. Methods Enzymol
111, 618–644.
|
| |
| 42. |
Buschle, M., Cotten, M., Kirlappos, H., Mechtler, K., Schaffner, G., Zauner, W., Birnstiel, M. L., and Wagner, E. (1995) Receptor-mediated
gene transfer into human T-lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex. Human Gene Ther
6, 753–761.
|
| |
| 43. |
Cotten, M., Wagner, E., Zatloukal, K., and Birnstiel, M. L. (1993) Chicken adenovirus (CELO virus) particles augment receptor-mediated
DNA delivery to mammalian cells and yield exceptional levels of stable transformants. J Virol. 67, 3777–3785.
|
| |
| 44. |
Thurnher, M., Wagner, E., Clausen, H., Mechtler, K., Rusconi, S., Dinter, A., Berger, E., Birnstiel, M., and Cotten, M. (1994)
Carbohydrate receptor-mediated gene transfer to human T-leukemic cells. Glycobiology
4, 429–435.
|
| |
| 45. |
Batra, R. K., Wang-Johanning, F., Wagner, E., Garver, R. I., and Cunel, D. T. (1994) Receptor-mediated gene delivery employing
lectin-bmding specificity Gene Ther
1, 255–260.
|
| |
| 46. |
Zatloukal, K., Schneeberger, A., Berger, M., Schmidt, W., Koszik, F., Kutil, R., Cotten, M., Wagner, E., Buschle, M., Maass,
G., Payer, E., Stingl, G., and Birnstiel, M. L. (1995) Elicitation of a systemic and protective antimelanoma immune response
by an IL-2-based vaccine; assessment of critical cellular and molecular parameters. J Immunol. 154, 3406–3419.
|
| |
| 47. |
Schreiber, M., Baumann, B., Cotten, M., Angel, P., and Wagner, E. F. (1995) c-Fos is an essential component of the mammalian
UV response. EMBOJ
14, 5338–5349.
|
| |
| 48. |
Goldsmith, K. T., Cunel, D. T., Engler, J. A., and Garver, R. I. (1994) Trans complementation of an ElA-deleted adenovirus
with codehvered El A sequences to make recombinant adenoviral producer cells. Human Gene Ther
5, 1341–1348.
|
| |
| 49. |
Scana, A, Cunel, D. T., and Kay, M. A. (1995) Complementation of a human adenovirus early region 4 deletion mutant in 293
cells using adenovirus-polylysine-DNA complexes. Gene Ther
2, 295–298.
|
| |
| 50. |
von Ruden, T., Stingl, L., Cotten, M., Wagner, E., and Zatloukal, K. (1995) Generation of high titer retroviral vectors following
receptor-mediated adenovirus-augmented transfection of packaging cell lines. BioTechmques
18, 484–489.
|
| |
| 51. |
Chiocca, S., Baker, A., and Cotten, M. (1997) Identification of a novel antiapoptotic protein, GAM-1, encoded by the CELO
adenovirus J Virol
71, 3168–3177.
|
| |